Target ALS is proud to announce that three consortia have been selected for awards through our Biomarker Consortia Program. As new therapeutics begin moving the needle for people with ALS, the field ...

In 2011, Dr. Rosa Rademakers (VIB) and her team first identified the repeat expansion mutation in C9orf72 as a major genetic driver of ALS and FTD. However, since this breakthrough, scientists have ...

Whether you’re newly diagnosed, living with ALS, or caring for someone who is, you don’t have to navigate this alone. This resource center brings together trusted information from experts in the field ...

Fasciculations, or involuntary muscle twitches, happen to about 70% of people. While it’s typically benign, the condition can become a cause for concern when it starts happening frequently.

ALS is a devastating neurodegenerative disease, and while there is no cure, ongoing research continues to offer hope for more effective treatments. An individual at the forefront of these efforts is ...

At least 70 different drugs have been tested in clinical trials completed or on-going. Many of these treatments aim to dampen disease factors that arise after motor neuron degeneration has been ...

Amyotrophic lateral sclerosis (ALS) is a progressive, incurable neurodegenerative disease that leads to the irreversible degeneration of motor neurons. Motor neurons are the nerve cells in the spinal ...

The numbers behind ALS tell a powerful story, illuminating the urgent need for progress in combating this life-altering disease. With each new study, researchers uncover vital information about risk ...

When Dr. Stella Sarraf first asked if anyone looked at the retina to detect ALS, the answer was simple: no one knew. That question sparked a research journey that may change how we diagnose and screen ...

Epidemiology is the method used to study health outcomes and the frequency of diseases in different groups of people. It’s crucial for researchers to understand the epidemiology, and especially the ...

Among the most distressing and painful symptoms of ALS are digestive issues that accompany the disease’s progression. Constipation, abdominal pain, a feeling of fullness, nausea, and difficulty moving ...

Target ALS is proud to announce a powerful new resource for ALS researchers: a collection of 28 standardized, well-characterized, and accessible fibroblast-derived induced pluripotent stem cell (iPSC) ...